Clik here to view.
OptiNose – New Migraine Treatment: Data Presented At IHC 2013
OptiNose’s Breath Powered Nasal Delivery Device (1) Drug delivery technology corporation OptiNose Inc. has presented results of a pivotal phase III TARGET study at the International Headache Congress...
View ArticleClik here to view.
Superior Acute Migraine Treatment Through Transcept & SNBL Deal
New drug combines combines a muco-adhesive drug carrier of active DHE with a proprietary nasal powder drug delivery device (1) A new drug that is poised as a rapidly absorbed chemical in the treatment...
View ArticleClik here to view.
Health Canada Recalls GSK’s Imitrex
Potentially Infected Needles In Injection Form Of Imitrex (1) Pharmaceutical giant GlaxoSmithKline (GSK) has recalled lot number C637078 and C632842 of it’s migraine drug Imitrex. The recalled drug is...
View ArticleClik here to view.
Launch of Migraine Patch Zecuity Delayed: NuPathe Inc.
NuPathe Delays The Launch Of Zecuity To Early 2014 (1) The innovative neuroscience solutions company NuPathe Inc. has announced a delay in the launch of it’s product – a migraine patch that is worn...
View Article
